Benefit-Risk

Benefit-Risk

Author: Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry July 23, 2024 Duration: 31:51
Are you curious about how benefit-risk assessments in healthcare evolve? Do you wonder how patient preferences shape these evaluations? Today, I speak with Tommi Tervonen, a leading expert in this field, to answer these questions and more. Tommi, the Chief Scientist at Kielo Research in Zurich, brings nearly two decades of experience in Multi-Criteria Decision Analysis (MCDA), patient preferences, and benefit-risk evaluations. This episode sheds light on the past, present, and future of benefit-risk assessments and shows how incorporating patient input is transforming healthcare decisions. Join us as we dive deep into this fascinating topic and discover the importance of structured methodologies and patient-centric approaches in making informed healthcare choices.

Hosted by Alexander Schacht and Benjamin Piske, both practicing biometricians and leaders within the pharmaceutical industry, The Effective Statistician-in association with PSI is a conversation about the practical realities of the profession. This isn't a theoretical lecture series; it's a resource built from the ground up by statisticians who navigate the same challenges you do every day. The discussions focus on actionable strategies for increasing your influence and efficiency, whether you're analyzing data, presenting findings, or guiding a team. You'll hear perspectives on developing leadership qualities even without a formal management title, and gain insight into current debates within the scientific and regulatory communities. The aim is to provide context for the health sector's evolving landscape, translating complex industry dynamics into relevant knowledge for your work. Tune in for a candid exploration of what it means to be a modern statistician, designed to help you refine your approach and achieve a more significant impact. This podcast serves as a professional toolkit, created in association with PSI (Promoting Statistical Insight), for statisticians at any career stage looking to deepen their expertise and navigate their roles with greater confidence and clarity.
Author: Language: English Episodes: 100

The Effective Statistician - in association with PSI
Podcast Episodes
Early Development and The Dose Selection in the Immune-oncology [not-audio_url] [/not-audio_url]

Duration: 19:28
How do we find the right dose in immune-oncology trials? Is the traditional “maximum tolerated dose” approach still enough, or should we also focus on efficacy? In this episode of The Effective Statistician, I talk with…
Sharpen The Saw [not-audio_url] [/not-audio_url]

Duration: 17:25
Are you feeling stuck or overwhelmed in your work as a statistician? Do you wonder how to stay sharp and maintain balance while tackling complex challenges? In this Friday episode of The Effective Statistician, my co-hos…
Introduction to Dealing with Non-proportional Hazards [not-audio_url] [/not-audio_url]

Duration: 43:25
Have you faced the challenge of dealing with non-proportional hazards in survival analysis? In this episode, I team up with Kaspar Rufibach, a statistical methodology expert, to break down what proportional hazards mean,…
Clinical Development of Gene Therapies [not-audio_url] [/not-audio_url]

Duration: 29:13
What makes gene therapy so different from traditional drug development? How do we address safety when each patient only receives a single dose? And why are statisticians so essential in this process? In this episode of T…
Statistical Topics in Gene Therapy [not-audio_url] [/not-audio_url]

Duration: 42:55
What if we could target genetic diseases at their root, offering lifelong cures instead of temporary solutions? And what role do statisticians play in making this breakthrough possible? In this episode of The Effective S…
Clinical Development Plans [not-audio_url] [/not-audio_url]

Duration: 35:59
What does it take to create an effective clinical development plan? How do our early decisions shape the path of a compound through clinical phases? And how can statisticians actively balance the demands of science, spee…
The Most Important Things You Need to Know About AI And ML [not-audio_url] [/not-audio_url]

Duration: 45:04
Have you wondered how large language models (LLMs) like ChatGPT are transforming the way we work? How can AI tools boost efficiency in statistics and pharmaceutical research? In this episode of The Effective Statistician…